Press Releases



All Releases
View Summary Sangamo BioSciences Announces Participation In The 3rd Annual Regen Med Investor Day Meeting In New York
Mar 18, 2015
PDF 76.3 KB Add to Briefcase
View Summary Sangamo BioSciences CEO To Present State Of The Industry Address At Alliance For Regenerative Medicine's Advanced Therapies Summit
Mar 9, 2015
PDF 73.7 KB Add to Briefcase
View Summary Sangamo BioSciences Presents New Clinical Data at CROI 2015 From Trial of ZFP Therapeutic® Designed to Provide Functional Control of HIV
Feb 26, 2015
PDF 51.7 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Presentation At The Cowen And Company 35th Annual Health Care Conference
Feb 25, 2015
PDF 43.0 KB Add to Briefcase
View Summary Sangamo BioSciences Presents Data At 11th Annual WorldSymposium™ Meeting Supporting In Vivo Protein Replacement Platform Approach For The Treatment Of Lysosomal Storage Disorders
Feb 12, 2015
PDF 48.1 KB Add to Briefcase
View Summary Sangamo BioSciences Reports Fourth Quarter and Full Year 2014 Financial Results
Feb 10, 2015
PDF 54.4 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Presentation At The 2015 Leerink Global Healthcare Conference
Feb 5, 2015
PDF 42.8 KB Add to Briefcase
View Summary Sangamo BioSciences Announces FDA Acceptance of IND to Initiate Clinical Trial of its Novel ZFP Therapeutic® for Beta-Thalassemia
Feb 4, 2015
PDF 47.5 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Fourth Quarter and Full Year 2014 Conference Call and Webcast
Feb 3, 2015
PDF 43.2 KB Add to Briefcase
View Summary Sangamo BioSciences To Highlight 2015 Catalysts And Advancement Of ZFP Therapeutic Programs At The 33rd Annual J.P. Morgan Healthcare Conference
Jan 12, 2015
PDF 47.2 KB Add to Briefcase
View Summary Sangamo BioSciences Announces In-Licensing Of mRNA Delivery Technology And Expansion Of Therapeutic Pipeline Opportunities For Sangamo's In Vivo ZFN Genome-Editing Platform
Jan 8, 2015
PDF 47.1 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Presentation At The 33rd Annual J.P. Morgan Healthcare Conference
Jan 5, 2015
PDF 42.9 KB Add to Briefcase
View Summary Sangamo BioSciences Presents New Data at American Society of Hematology Meeting Demonstrating Broad Application of ZFN Mediated Genome-Editing Approach to Therapeutics for Hemophilia and Lysosomal Storage Disorders
Dec 8, 2014
PDF 49.9 KB Add to Briefcase
View Summary Sangamo BioSciences Presents Study At Society For Neuroscience Meeting Demonstrating In Vivo Reversal Of Huntington's Disease Signs And Symptoms
Nov 19, 2014
PDF 48.4 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Presentation at the 26th Annual Piper Jaffray Healthcare Conference
Nov 18, 2014
PDF 14.4 KB Add to Briefcase
View Summary Sangamo BioSciences President and CEO Edward Lanphier to Serve as Chairman of the Alliance for Regenerative Medicine
Nov 10, 2014
PDF 45.9 KB Add to Briefcase
View Summary Sangamo BioSciences Reports Third Quarter 2014 Financial Results
Oct 22, 2014
PDF 53.6 KB Add to Briefcase
View Summary Sangamo BioSciences ZFP Therapeutic Program in HIV/AIDS Featured at Three Major Scientific Conferences in October 2014
Oct 16, 2014
PDF 91.0 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Third Quarter 2014 Conference Call and Webcast
Oct 15, 2014
PDF 41.9 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Target Date For First IND For Sangamo's In Vivo ZFN Genome-Editing Platform For Monogenic Diseases
Sep 10, 2014
PDF 46.2 KB Add to Briefcase
Showing 1-20 of 508 Page: 1 2 3 4 5 ... 26  Next 20
Add to Briefcase = add release to Briefcase

Stock Quote

Ticker:
SGMO
Exchange:
NASDAQ
Price:
14.91
Change:
- 0.12
Day High:
15.25
Day Low:
14.41
Volume:
921,900
4:00 PM ET on Mar 26, 2015

Shareholder Tools